The exam shows erythematous papules and vesicles on the upper and lower extremities, along with scattered crusted lesions and ...

Conference Call Information Rhythm Pharmaceuticals will host a live conference call and webcast at 8:00 a.m. ET on Wednesday, July 9, to discuss these clinical data. Participants may register for the ...

Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity - ...

Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced an oral presentation ...

Mental health and insurance providers must fix the system’s entrenched flaws to avoid the worst of the sustainability and ...

Bivamelagon achieved BMI reductions in patients with acquired hypothalamic obesity of -9.3% and -7.7% in 600mg and 400mg cohorts, respectively, at 14 weeks -- -- Post-hoc analysis showed BMI reduction ...

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of PROLIA®</ ...

In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...

After 8 months of taking the wrong medication, Miss G developed a rash. Her mother took her to the emergency department (ED) of the local hospital after 2 days of unsuccessfully trying to treat the ...

US FDA approves updated label for Eli Lilly's Kisunla with new dosing in early symptomatic Alzheimer's disease: Indianapolis Thursday, July 10, 2025, 14:00 Hrs [IST] Eli Lilly and ...

This study investigates how blindness affects sleep, dreams, and spatial awareness, revealing links between circadian rhythms ...